Abstract
The identification of immunological membrane markers on normal human mononuclear leukocytes has permitted their classification into a T (thymodependent) and a B (thymoindependent) lymphocyte group (2, 3, 19, 45, 47, 56, 57), as well as a third group “non-T non-B”, which includes monocytes (23) and other cells, the precise origin of which is still unclear (8).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aisenberg A.C. and Long J.C.: Lymphocyte surface characteristics in malignant lymphomas. Ann. J. Med., 58, 300 (1975).
Aiuti F. et al.: Identification, enumeration and isolation of B and T lymphocytes from human peripheral blood. Report of W.H.O. I.A.R.C., sponsored Workshop on human B and T cells. Scand. J. Immunol., 3, 521, (1974), (London 15–17 July 1974).
Belpomme D., Dantchev D., Du Rusquec E., Grandjon D., Huchet R., Pouillart P., Schwarzenberg L., Amiel J.L. and Mathé G.: T and B lymphocyte markers on the neoplastic cells of 20 patients with acute and 10 patients with chronic lymphoid leukemia. Biomedicine, 20, 109, (1974).
Belpomme D., Dantchev D., Du Rusquec E., Grandjon D., Huchet R., Pinon F., Pouillart P., Schwarzenberg L., Amiel J.L. and Mathé G.: La nature T ou B des cellures néoplastiques des leucémies lymphoïdes. Bull. Cancer, 61, 387 (1974).
Belpomme D., Dantchev D., Joseph R., Huchet R., Grandjon D., Santoro A. and Mathé G.: Further studies of acute and chronic leukemia T and B cell membrane markers and scanning electron microscopy. In: Current studies on standardization problems in clinical pathology, haematology and radiotherapy in Hodgkin’s disease, p. 143, Excerpta Médica, Amsterdam, ICS 348, (1975).
Belpomme D., Dantchev D., Joseph R., Santoro A., Feuilhade de Chauvin F., Grandjon D. and Mathé G.: Cell membrane markers of T and B lymphocytes and monocytes in leukemias and hematosarcomas. In: Biological characterization of human tumors, p. 298, Excerpta Médica, Amsterdam, ICS 375, (1976).
Belpomme D., Dantchev D., Joseph R., Santoro A., Feuilhade de Chauvin F., Lelarge N., Grandjon D., Pontvert D. and Mathé G.: Classification of leukemias and hematosarcomas based on cell membrane markers and scanning electron microscopy. In: Clinical Tumor Immunology, p. 131, eds. J. Wybran, Pergamon Press Oxford and New York, (1976).
Belpomme D., Joseph R. and Lelarge N.: Increase of null cells in patients submitted to long term active immunotherapy. Cancer Immunol. Immunoth., 1, 113 (1976).
Belpomme D., Lelarge N., Joseph R. and Mathé G.: An immunological classification of leukemias and hematosarcomas based on cell membrane markers with special reference to null cell disorders. Eur. J. of Cancer, (1976) (In press).
Belpomme D., Lelarge N., Feuilhade de Chauvin F., Joseph R. and Mathé G.: An immunological classification of leukemias and hematosarcomas based on cell membrane markers with special reference to null-cell disorders. In: Lymphocytes, Macrophages and Cancer, p. 98, (G. Mathé, I. Florentin, M.C. Simmler, eds), Springer Verlag, (1976).
Borella L. and Sen L.T.: Cell surface markers on lymphoblasts from acute lymphocytic leukemia. J. Immunol., 111, 1257, (1973).
Brouet J.C., Valensi F., Daniel M.T., Flandrin G., Preud’Homme J.L., and Seligman M.: Immunological classification of acute lymphoblastic leukemias: Evaluation of its clinical significance in a hundred patients. British. J. of Haematology, 33, 319 (1976).
Brouet J.C., Labaume S. and Seligman M.: Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata. Br. J. Cancer, 31, 121, (1975).
Brouet J.C., Preud’Homme J.L., Flandrin G., Chelloul N. and Seligman M.: Membrane markers in “Histiocytic” lymphomas (Reticulin cell sarcomas). J. Natl. Cancer Inst., 56, 631, (1976).
Braylan R.G., Jaffe E.S. and Berard C.W.: Malignant lymphomas: Current classification and new observations (Sommers S.C. ed) In: Pathology Annual, p. 213, 1975. New York Appleton Century Crofts, 1975.
Catovsky D., Goldman J.M., Okos A., Frisch B. and Galton D.A.G.: T lymphoblastic leukemia: a distinct variant of acute leukemia. Brit. Med. J., 2, 643, (1974).
Chin A.H., Saiki J.H., Trujillo J.M. and Williams R.C.: Peripheral blood T and B lymphocytes in patients with lymphoma and acute leukemia. Clin. Immunol. Immunopath., 1, 499, (1973).
Davey R.R. and Gottlieb A.J.: Lymphocyte surface markers in acute lymphocytic leukemia. Am. J. of Clinic. Path., 62, 818, (1974).
Froland S. and Natvig J.B.: Surface-bound immunoglobulin as a marker of B lymphocytes in man. Nature (New Biol.), 234, 251, (1971).
Gajl-Peczalska K., Bloomfield C.D., Nesbit M.E. and Kersey J.K.: B-cell markers on lymphoblasts in acute lymphoblastic leukemia. Clin. Exp. Immunol., 17, 561, (1974).
Gajl-Peczalska J., Bloomfield C.D., Coccia P.F., Sosin H., Brunning R.D., and Kersey J.H.: B and T-cell lymphomas analysis of blood and lymph nodes in 87 patients. The Am. J. of Med., 59, 674 (1975).
Gross L.: Effect of thymectomy on development of leukemia in CH mice inoculated with “passage” virus. Proc. Soc. Exp. Biol. (NY), 100, 325, (1959).
Hainz H.: Human monocytes: distinct receptor sites for the third component and for immunoglobulin G. Science, 1662, 1281, (1968).
Hayhoe F.G. and Flemans R.: An atlas of haematological cytology, London, (1969) Wolfe Medical Books.
Jaffe E.S., Shevach E.M., Frank M.M., Veraud C.W. and Green I.: Nodular lymphoma: evidence for origin from follicular B-lymphocytes. New Engl. J. Med., 290, 813, (1974).
Johansson B., Klein E. and Haglund S.: Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas. Clinical Immunol, and Immunoth., 5, 119, (1976).
Kaplan J., Mastrangelo R. and Peterson W.D.: Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes. Cancer Research, 34, 521, (1974).
Kersey J.H., Sabad A., Gajl-Peczalska K., Hallgren H.M., Yunis E.J. and Nesbit M.: Acute lymphoblastic leukemia cells with T (thymo-derived) lymphocyte markers. Science, 182, 1355, (1973).
Kersey J.H., Nesbit M.E., Luckasen H.R., Sabad A., Yunis E.J. and Gajl-Peczalska K.J.: Acute lymphoblastic leukemic and lymphoma cells with thymus derived (T) markers. Mayo Clinic Proc, 49, 584, (1974).
Kersey J., Nesbit M., Hallgrer H., Sabad A., Yunis E. and Gajl-Peczalska K.: Evidence for origin of certain childhood acute lymphoblastic leukemias and lymphomas in thymus derived lymphocytes. Cancer, 36, 1348, (1975).
Lennert K., Stein H., Kaiserling E.: Cytological and functional criteria for the classification of malignant lymphoma. Br. J. Cancer, suppl. 2, 31, 29, (1975).
Lukes R.J. and Collins R.D.: Immunologic characterization of human malignant lymphomas. Cancer, 34, 1488 (1974).
Mann R.B., Jaffe E.S., Braylan R.C., Egglaston J.C., Ransom L., Kize H. and Berard C.W.: Immunologic and morphologic studies of T cell lymphoma. Am. J. Med., 58, 307 (1975).
Mathé G., Pouillart P., Sterescu M., Amiel J.L., Schwarzenberg L., Schneider M., Hayat M., De Vassal F. and Jasmin C.: Sub-division of classical varieties of acute leukemia. Correlation with prognosis and cure expectancy. Europ. J. Clin. Biol. Res., 16, 554, (1971).
Mathé G., and Belpomme D.: T and B lymphocytic nature of leukemias and lymphosarcomas: a new but still uncertain parameter for their classification. Biomedicine, 20, 81, (1974).
Mathé G., Belpomme D., Dantchev D., Pouillart P., Jasmin C., Misset J.L., Musset M., Amiel J.L., Schlumberger J.R., Schwarzenberg L., Hayat M., De Vassal F. and Lafleur M.: Immunoblastic acute lymphoid leukemia. Biomedicine, 20, 333, (1974).
Mathé G., Belpomme D., Dantchev D., and Pouillart P.: Progress in the classification of lymphoid and/or monocytoid leukemias and of lympho and reticulosarcomas (non Hodgkin’s lymphomas). Biomedicine, 22, 177, (1975).
Mathé G., Belpomme D., Dantchev D., Pouillart P., Schlumberger J.R., and Lafleur M.: Leukemic lymphosarcomas: respective prognosis of the three types: prolymphocytc, lymphoblastic (or lymphoblastoid) and immunoblastic. Blood Cells, 1, 25, (1975).
Mathé G., Belpomme D., Dantchev D., Khalil A., Afifi A.M., Taleb N., Pouillart P., Schwarzenberg L., Hayat M., De Vassal F., Jasmin C., Misset J.L. et Musset M.: Immunoblastic lymphosarcomas. A cytological and clinical entity? Biomedicine, 22, 473, (1975).
Mathé G. and Rappaport H.: Histological and cytological typing of neoplastic diseases of haematopoietic and lymphoid tissues, W.H.O., Geneva, (1976).
Mathé G., De Vassal F., Delago M., Pouillart P., Belpomme D., Joseph R., Schwarzenberg L., Amiel J.L., Schneider M., Cattan A., Musset M., Misset J.L. and Jasmin C.: 1975 current results of the first 100 cytologically typed acute lymphoid leukemia submitted to BCG active immunotherapy. Cancer Immunol. Immunoth., 1, 77, (1976).
Misset J.L., Pouillart P., Amiel J.L., Schwarzenberg L., Hayat M., De Vassal F., Musset M., Belpomme D., Jasmin C., Albahary C., Depierre R. and Mathé G.: Combinaison d’adryamicine, de VM26, de cyclophosphamide et de prednisone (AVmCP) pour la chimiothérapie des lymphosarcomes et reticulosarcomes aux stades ou formes topographiques III et IV. Nle. Presse Médicale, 4, 3117, (1975).
Nathwani B.N., Kim H. and Rappaport H.: Malignant lymphoma, lymphoblastic. Cancer, 38, 964, (1976).
Peter C.R., Mackenzie M.R., Glassy F.J.: T or B cell origin of some non Hodgkin’s lymphomas. Lancet, 2, 686, (1974).
Preud’Homme J.L. and Seligmann M.: Surface bound immunoglobulins a cell marker in human proliferative diseases. Blood, 40, 777, (1972).
Rappaport H., Winter W.J. and Hicks E.B.: Follicular lymphoma. A reevalution of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer, 9, 792, (1956).
Ross G.D., Rabellino E.M., Polley M.J. and Grey H.M.: Combined studies of complement receptor and surface immunoglobulin bearing cells and sheep erythrocyte rosette forming cells in normal and leukemic human lymphocytes. J. Clin. Invest., 52, 377, (1973).
Schedel I., Fink P.C., Bodenberger H. and Deicher H.: Monoclonal lymphoid cell surface immunoglobulins with tumor-specific determinant in lymphosarcoma. Clin. Immunol. Immunopath., 5, 74, (1976).
Seligman M., Preud’Homme J.L. and Brouet J.C.: B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transpl. Rev., 16, 85, (1973).
Sen L. and Borella L.: Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N. Engl. J. Med., 292, 828, (1975).
Smith J.L., Barker C.R., Klein G.P. and Collins R.D.: Characterization of malignant mediastinal lymphoid neoplasm (Sternberg sarcoma) as thymic in origin. The Lancet, i, 74, (1973).
Stathopoulos G., Davies A.J.S., Papamichail M., Holborow E.J., and Wiltshaw E.: Origin of malignant cells in lymphoma apparently originating in anterior mediastinum. The Lancet, 1, 927, (1974).
Stein H., Lennert K., Parwaresch M.R.: Malignant lymphomas of a cell type. Lancet, ii, 855, (1972).
Sternberg C.: Leukosarcomatose und Myeloblastenleukämie. Brit. Path., 61, 75, (1916).
Tsukimoto I., Wong K.Y. and Lampkin B.C.: Surface markers and prognostic factors in acute lymphoblastic leukemia. N. Engl. J. Med., 294, 245, (1976).
Wilson J.D. and Nossal C.J.V.: Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukemia. The Lancet, 2, 788, (1971).
Wybran J., Carr M.C. and Fudenberg H.H.: The human rosette forming cells as a marker of population of thymus derived cells. J. Clin. Invest., 51, 2537, (1972).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Belpomme, D., Lelarge, N., Mathé, G., Davies, A.J.S. (1977). Etiological, Clinical and Prognostic Significance of the T-B Immunological Classification of Primary Acute Lymphoid Leukemias and Non Hodgkin’s Lymphomas. In: Thierfelder, S., Rodt, H., Thiel, E. (eds) Immunological Diagnosis of Leukemias and Lymphomas. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66639-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-66639-1_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-08216-3
Online ISBN: 978-3-642-66639-1
eBook Packages: Springer Book Archive